Denise Pollard-Knight, Director at OncoMed Pharmaceuticals Inc (OMED), sold 25,000 shares at $22.10 ($540K) on 2014-12-05, disclosed to the SEC on 2014-12-05.
Open-market sale of $540k OMED by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.58 | 24,245 | $523K | 96.9% |
| 2 | $22.10 | 755 | $17K | 3.1% |
| Total | $21.60 avg | 25,000 | $540K | 100% |
| Filing → |
| OMED | SELL | 2014-12-23 | $448K | — | Filing → |
| OMED | SELL | 2014-12-10 | $717K | — | Filing → |
| OMED | SELL | 2014-07-02 | $271K | — | Filing → |